{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:53:10Z","timestamp":1786981990200,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01 AA029267"],"award-info":[{"award-number":["R01 AA029267"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30 DA035772"],"award-info":[{"award-number":["P30 DA035772"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s11606-024-09002-3","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T13:02:16Z","timestamp":1724677336000},"page":"2708-2715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Medications for Alcohol Use Disorder: Rates and Predictors of Prescription Order and Fill in Outpatient Settings"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-9176","authenticated-orcid":false,"given":"Dominic","family":"Hodgkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa B.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alene","family":"Kennedy-Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hocine","family":"Azeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance M.","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Uscher-Pines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiden A.","family":"Huskamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"9002_CR1","unstructured":"Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration. https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-annual-national-report. Published 2023. Accessed 12\/27\/2023."},{"key":"9002_CR2","unstructured":"Centers for Disease Control and Prevention. Alcohol and Public Health: Alcohol-Related Disease Impact (ARDI) \u2013 Average for United States 2015\u20132019 Alcohol-Attributable Deaths Due to Excessive Alcohol Use. Available at: www.cdc.gov\/ARDI. Published 2023. Accessed 12\/27\/2023."},{"issue":"17","key":"9002_CR3","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.2023.19761","volume":"330","author":"M McPheeters","year":"2023","unstructured":"McPheeters M, O\u2019Connor EA, Riley S, et al. Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis. Jama. 2023;330(17):1653-1665.","journal-title":"Jama."},{"issue":"1","key":"9002_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","volume":"175","author":"VI Reus","year":"2018","unstructured":"Reus VI, Fochtmann LJ, Bukstein O, et al. The American psychiatric association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018;175(1):86-90.","journal-title":"Am J Psychiatry."},{"key":"9002_CR5","unstructured":"Department of Veterans Affairs\/ Department of Defense. VA\/DoD Clinical Practice Guideline For The Management Of Substance Use Disorders. Version 4.0. 2021."},{"issue":"4","key":"9002_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1370\/afm.2997","volume":"21","author":"A Bhardwaj","year":"2023","unstructured":"Bhardwaj A, Sousa JL, Huskamp HA, et al. Prescribing medications for alcohol use disorder: a qualitative study of primary care physician decision-making. Ann Fam Med. 2023;21(4):332\u2013337.","journal-title":"Ann Fam Med."},{"issue":"1","key":"9002_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13722-019-0151-7","volume":"14","author":"HJ Hagedorn","year":"2019","unstructured":"Hagedorn HJ, Wisdom JP, Gerould H, et al. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes. Addict Sci Clin Pract. 2019;14(1):24.","journal-title":"Addict Sci Clin Pract."},{"issue":"4","key":"9002_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1037\/a0030949","volume":"10","author":"AHS Harris","year":"2013","unstructured":"Harris AHS, Ellerbe L, Reeder RN, et al. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychol Serv. 2013;10(4):410-419.","journal-title":"Psychol Serv."},{"issue":"4","key":"9002_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1176\/ps.2010.61.4.392","volume":"61","author":"AH Harris","year":"2010","unstructured":"Harris AH, Kivlahan DR, Bowe T, Humphreys KN. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv. 2010;61(4):392-398.","journal-title":"Psychiatr Serv."},{"issue":"1","key":"9002_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13722-016-0063-8","volume":"11","author":"AH Harris","year":"2016","unstructured":"Harris AH, Bowe T, Hagedorn H, et al. Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness. Addict Sci Clin Pract. 2016;11(1):15.","journal-title":"Addict Sci Clin Pract."},{"key":"9002_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jpsychires.2015.07.016","volume":"69","author":"AD Rubinsky","year":"2015","unstructured":"Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. J Psychiatr Res. 2015;69:150-157.","journal-title":"J Psychiatr Res."},{"key":"9002_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jsat.2018.08.002","volume":"94","author":"D McCarty","year":"2018","unstructured":"McCarty D, Gu Y, Renfro S, Baker R, Lind BK, McConnell KJ. Access to treatment for alcohol use disorders following Oregon\u2019s health care reforms and Medicaid expansion. J Subst Abuse Treat. 2018;94:24-28.","journal-title":"J Subst Abuse Treat."},{"issue":"1","key":"9002_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsat.2013.01.004","volume":"45","author":"CP Thomas","year":"2013","unstructured":"Thomas CP, Garnick DW, Horgan CM, Miller K, Harris AH, Rosen MM. Establishing the feasibility of measuring performance in use of addiction pharmacotherapy. J Subst Abuse Treat. 2013;45(1):11-18.","journal-title":"J Subst Abuse Treat."},{"issue":"1","key":"9002_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13722-019-0147-3","volume":"14","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey PJ, Kladney M, Cunningham CO, Bachhuber MA. Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD). Addict Sci Clin Pract. 2019;14(1):19.","journal-title":"Addict Sci Clin Pract."},{"issue":"6","key":"9002_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/acer.14837","volume":"46","author":"L Chockalingam","year":"2022","unstructured":"Chockalingam L, Burnham EL, Jolley SE. Medication prescribing for alcohol use disorders during alcohol-related encounters in a Colorado regional healthcare system. Alcohol Clin Exp Res. 2022;46(6):1094-1102.","journal-title":"Alcohol Clin Exp Res."},{"key":"9002_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jsat.2019.11.008","volume":"110","author":"KA Hallgren","year":"2020","unstructured":"Hallgren KA, Witwer E, West I, et al. Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network. J Subst Abuse Treat. 2020;110:18-27.","journal-title":"J Subst Abuse Treat."},{"issue":"4","key":"9002_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/08897077.2016.1189477","volume":"37","author":"T Rieckmann","year":"2016","unstructured":"Rieckmann T, Muench J, McBurnie MA, et al. Medication-assisted treatment for substance use disorders within a national community health center research network. Subst Abus. 2016;37(4):625-634.","journal-title":"Subst Abus."},{"issue":"7","key":"9002_CR18","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s11606-020-06454-1","volume":"36","author":"E Bernstein","year":"2021","unstructured":"Bernstein E, Guo N, Goto T, Rothberg MB. Characterizing the variation of alcohol cessation pharmacotherapy in primary care. J Gen Intern Med. 2021;36(7):1989-1996.","journal-title":"J Gen Intern Med."},{"issue":"4","key":"9002_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1080\/08897077.2020.1809604","volume":"42","author":"ZJ Peters","year":"2021","unstructured":"Peters ZJ, Kincaid MW, Greenberg JG, Quah RF, Curry JC. Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder. Subst Abus. 2021;42(4):638-645.","journal-title":"Subst Abus."},{"issue":"1","key":"9002_CR20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/08897077.2022.2074604","volume":"43","author":"AR Williams","year":"2022","unstructured":"Williams AR, Johnson KA, Thomas CP, et al. Opioid use disorder Cascade of care framework design: a roadmap. Subst Abus. 2022;43(1):1207-1214.","journal-title":"Subst Abus."},{"issue":"8","key":"9002_CR21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/cid\/cit420","volume":"57","author":"MJ Mugavero","year":"2013","unstructured":"Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164-1171.","journal-title":"Clin Infect Dis."},{"issue":"12","key":"9002_CR22","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E Von Elm","year":"2014","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP;\u00a0 Strobe Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495-1499.","journal-title":"Int J Surg."},{"key":"9002_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jsat.2019.11.002","volume":"109","author":"BJ Oldfield","year":"2020","unstructured":"Oldfield BJ, McGinnis KA, Edelman EJ, et al. Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV. J Subst Abuse Treat. 2020;109:14-22.","journal-title":"J Subst Abuse Treat."},{"key":"9002_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsat.2018.06.001","volume":"91","author":"AR Williams","year":"2018","unstructured":"Williams AR, Nunes EV, Bisaga A, et al. Developing an opioid use disorder treatment cascade: a review of quality measures. J Subst Abuse Treat. 2018;91:57-68.","journal-title":"J Subst Abuse Treat."},{"key":"9002_CR25","unstructured":"US Census Bureau. Income in the United States: 2021. 2022. Report Number P60\u2013276."},{"key":"9002_CR26","doi-asserted-by":"publisher","first-page":"108540","DOI":"10.1016\/j.jsat.2021.108540","volume":"133","author":"JR Morgan","year":"2022","unstructured":"Morgan JR, Quinn EK, Chaisson CE, et al. Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder. J Subst Abuse Treat. 2022;133:108540.","journal-title":"J Subst Abuse Treat."},{"issue":"4","key":"9002_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","volume":"25","author":"MA Fischer","year":"2010","unstructured":"Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284-290.","journal-title":"J Gen Intern Med."},{"issue":"2","key":"9002_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1530-0277.2006.00022.x","volume":"30","author":"HR Kranzler","year":"2006","unstructured":"Kranzler HR, Koob G, Gastfriend DR, Swift RM, Willenbring ML. Advances in the pharmacotherapy of alcoholism: challenging misconceptions. Alcohol: Clin Exp Res. 2006;30(2):272-281.","journal-title":"Alcoholism Clin Exp Res."},{"issue":"1","key":"9002_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.15288\/jsa.2000.61.134","volume":"61","author":"RG Rychtarik","year":"2000","unstructured":"Rychtarik RG, Connors GJ, Dermen KH, Stasiewicz PR. Alcoholics Anonymous and the use of medications to prevent relapse: an anonymous survey of member attitudes. J Stud Alcohol. 2000;61(1):134-138.","journal-title":"J Stud Alcohol."},{"key":"9002_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.drugalcdep.2017.06.011","volume":"178","author":"EC Williams","year":"2017","unstructured":"Williams EC, Gupta S, Rubinsky AD, et al. Variation in receipt of pharmacotherapy for alcohol use disorders across racial\/ethnic groups: a national study in the U.S. Veterans Health Administration. Drug Alcohol Depend. 2017;178:527-533.","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"9002_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/acer.13944","volume":"43","author":"JL Mellinger","year":"2019","unstructured":"Mellinger JL, Fernandez A, Shedden K, et al. Gender disparities in alcohol use disorder treatment among privately insured patients with alcohol-associated cirrhosis. Alcohol Clin Exp Res. 2019;43(2):334-341.","journal-title":"Alcohol Clin Exp Res."},{"issue":"4","key":"9002_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/YCO.0000000000000943","volume":"37","author":"A Cheetham","year":"2024","unstructured":"Cheetham A, Grist E, Nielsen S. Pharmacist-prescriber collaborative models of care for opioid use disorder: an overview of recent research. Curr Opin Psychiatry. 2024;37(4):251-257.","journal-title":"Curr Opin Psychiatry."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-09002-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:08:50Z","timestamp":1764266930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-09002-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":32,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["9002"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-09002-3","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}